The Institute for Systems Biology Licenses MetaCore™ from GeneGo
News Jul 25, 2007
All ISB researchers will have access to GeneGo pathway analysis and systems biology tools. MetaCore will be integrated with Cytoscape, an open source network visualization software supported by ISB. GeneGo and ISB also plan to collaborate on several research projects.
ISB is a non-profit research institute headquartered in Seattle and dedicated to the study and application of systems biology. ISB seeks to unravel the mysteries of human biology and identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS.
ISB’s systems approach integrates biology, computation and technological development, enabling scientists to analyze all elements in a biological system rather than one gene or protein at a time.
“The manually curated content available from GeneGo is exceptional and will allow us to advance our projects,” said Dr Nat Goodman, a Senior Research Scientist at ISB. “We are initiating several research projects together that will hopefully result in publications.”
“We are happy to welcome ISB as a customer and collaborator,” said Julie Bryant, GeneGo’s VP of Business Development. “ISB, led by Dr. Lee Hood, is the premium academic institution in our field, with outstanding research and vision. We are looking forward to working with them in systems biology of human diseases.”
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE